Modern Human Immunodeficiency Virus Therapy: Progress and Prospects-Reference-Cited by-同舟云学术

Modern Human Immunodeficiency Virus Therapy: Progress and Prospects

Published:2018-12-29 Issue:1 Volume:105 Page:61-70
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Flexner Charles¹^ORCID

Affiliation:

1. Divisions of Clinical Pharmacology and Infectious DiseasesDepartments of Medicine, Pharmacology and Molecular Sciences, and International HealthSchool of Medicine and Bloomberg School of Public HealthJohns Hopkins University Baltimore Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1284

Reference55 articles.

1. Projections of Global Mortality and Burden of Disease from 2002 to 2030

2. Department of Health and Human Services (DHHS).Guidelines for the use of antiretroviral agents in HIV‐1 infected adults and adolescents. . Last updated 30 May 2018.

3. Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study

4. HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy

5. Survival After AIDS Diagnosis in Adolescents and Adults During the Treatment Era, United States, 1984-1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication;International Journal of Molecular Sciences;2024-03-25

2. We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy;The Lancet HIV;2023-03

3. HIV Pharmacology Data Repository (PDR): Setting the New Information Sharing Standard for Pharmacokinetic Studies;2023-02-13

4. Challenges in designing antiviral agents;Viral Infections and Antiviral Therapies;2023

5. Tuning the release rate of rilpivirine from PLGA-based in situ forming implants;Polymer Bulletin;2022-12-01